LogicBio Therapeutics Announces Pricing of Initial Public Offering
October 18, 2018 19:06 ET
|
LogicBio Therapeutics
CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant...